JP2025503533A5 - - Google Patents
Info
- Publication number
- JP2025503533A5 JP2025503533A5 JP2024539285A JP2024539285A JP2025503533A5 JP 2025503533 A5 JP2025503533 A5 JP 2025503533A5 JP 2024539285 A JP2024539285 A JP 2024539285A JP 2024539285 A JP2024539285 A JP 2024539285A JP 2025503533 A5 JP2025503533 A5 JP 2025503533A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antigen
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021143087 | 2021-12-30 | ||
| CNPCT/CN2021/143087 | 2021-12-30 | ||
| PCT/CN2022/143358 WO2023125796A1 (en) | 2021-12-30 | 2022-12-29 | Human antibodies against fap-alpha |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503533A JP2025503533A (ja) | 2025-02-04 |
| JP2025503533A5 true JP2025503533A5 (https=) | 2025-12-22 |
Family
ID=86998178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024539285A Pending JP2025503533A (ja) | 2021-12-30 | 2022-12-29 | Ｆａｐ－アルファに対するヒト抗体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250297032A1 (https=) |
| EP (1) | EP4457346A1 (https=) |
| JP (1) | JP2025503533A (https=) |
| CN (2) | CN118974258A (https=) |
| WO (1) | WO2023125796A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120309735A (zh) * | 2024-01-15 | 2025-07-15 | 迈威(上海)生物科技股份有限公司 | 重组抗fap抗体及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0953639A1 (en) * | 1998-04-30 | 1999-11-03 | Boehringer Ingelheim International GmbH | FAPalpha-specific antibody with improved producibility |
| EP1268550A2 (en) * | 2000-03-17 | 2003-01-02 | Boehringer Ingelheim Pharma KG | Human fap-alpha-specific antibodies |
| DE10013286A1 (de) * | 2000-03-17 | 2001-09-20 | Boehringer Ingelheim Pharma | Humane FAP-alpha-spezifische Antikörper |
| PE20021080A1 (es) * | 2001-04-12 | 2003-02-12 | Boehringer Ingelheim Int | Un anticuerpo especifico fapo bibh1 en el tratamiento del cancer |
| CN101426527A (zh) * | 2006-02-03 | 2009-05-06 | 米迪缪尼有限公司 | 蛋白质制剂 |
| CN109796532B (zh) * | 2017-11-17 | 2024-09-10 | 恺兴生命科技(上海)有限公司 | 靶向成纤维激活蛋白α的结合单元及其应用 |
| CN111118063B (zh) * | 2019-12-05 | 2023-04-18 | 吉林大学 | 以FAPα和survivin为基础的DNA及其在制备肿瘤疫苗中的应用 |
-
2022
- 2022-12-29 CN CN202280092987.7A patent/CN118974258A/zh active Pending
- 2022-12-29 US US18/724,173 patent/US20250297032A1/en active Pending
- 2022-12-29 JP JP2024539285A patent/JP2025503533A/ja active Pending
- 2022-12-29 EP EP22915046.1A patent/EP4457346A1/en active Pending
- 2022-12-29 WO PCT/CN2022/143358 patent/WO2023125796A1/en not_active Ceased
- 2022-12-29 CN CN202511419738.6A patent/CN121342995A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110799539B (zh) | 抗4-1bb抗体及其制备和使用方法 | |
| DK2493503T3 (en) | DOSAGE SCHEDULE FOR THE ADMINISTRATION OF A CD19xCD3 bispecific antibody | |
| JP2011509245A5 (https=) | ||
| JP2017532952A5 (https=) | ||
| JP2019536430A5 (https=) | ||
| JP2006020633A (ja) | 糸球体腎炎および他の炎症性疾患の治療のための組成物および方法 | |
| WO2018137576A1 (zh) | 抗pd-1单克隆抗体及其制备方法和应用 | |
| JP2023515223A5 (https=) | ||
| JP2022553922A5 (https=) | ||
| JP2024537323A5 (https=) | ||
| JP2023540526A5 (https=) | ||
| JP2023549537A5 (https=) | ||
| JP2023543031A5 (https=) | ||
| JP2018528776A5 (https=) | ||
| JP2024001073A5 (https=) | ||
| JP2023519099A5 (https=) | ||
| JP2025069432A5 (https=) | ||
| JP2023548529A5 (https=) | ||
| JP2021530244A5 (https=) | ||
| JP2022512646A5 (https=) | ||
| JP2023544143A5 (https=) | ||
| JP2025512953A5 (https=) | ||
| JP2023511898A5 (https=) | ||
| JP2023547506A5 (https=) | ||
| JP2022532991A5 (https=) |